Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-BN-RSV Vaccine Challenge Study in Healthy Adults
NCT04752644Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Feb 2021
- Primary completion
- Jun 2021
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus infection (RSV) comparing MVA-BN-RSV with Placebo (2 arms). Primary endpoint: Area under the viral load-time curve of RSV-A Memphis 37b. Started Feb 2021; status: completed.
02
Drugs
MVA-BN-RSV
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT04752644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04752644.